Given our evidence showing that inhibition of β-catenin-dependent WNT signalling reduced a number of markers of an A9 midbrain dopaminergic phenotype while increasing NR0B1 and NR0B2 expression, we wondered whether WNT signalling systems could be perturbed in PD. This evidence concerns the gene NR0B2 and Parkinson disease.